Meticulous Research®, a prominent global market research firm, has recently published a study titled, 'Veterinary Immunodiagnostics Market by Product (Analyzers, Consumables {Leukemia, Influenza, BTV, FMD, BTB, BHV}), Animal (Livestock, Companion), Technology (ELISA, Radioimmunoassay, Rapid Tests), End User (Hospitals, Point of care)—Global Forecast to 2029.'

In its latest report, Meticulous Research® forecasts significant growth in the veterinary immunodiagnostics market, projecting a Compound Annual Growth Rate (CAGR) of 9.3% from 2022 to reach an estimated value of $2.71 billion by 2029. This growth is driven by factors such as the increasing prevalence of animal diseases, advancements in immunodiagnostic technology, and the availability of specialized tests. Furthermore, the rising pet population and demand for animal-derived products contribute to expanding market opportunities. Despite these prospects, challenges remain in developing nations due to inadequate diagnostic infrastructure.

The veterinary immunodiagnostics market is segmented comprehensively by Product (Analyzers and Consumables), Animal Type (Companion Animals and Livestock), Technology (ELISA, Radioimmunoassay, Rapid Tests, and Others), End User (Reference Laboratories, Veterinary Hospitals & Clinics, and Point of Care Testing), and Geography. This segmentation enables detailed analysis of market dynamics and competition at regional and country levels.

In 2022, the consumables segment is anticipated to dominate the market due to its high sensitivity, accuracy, rapid diagnosis capabilities, cost-effectiveness, and availability of disease-specific immunoassays. Technologically, the ELISA segment is expected to hold the largest market share, driven by ongoing advancements in biomarkers and adoption of automated platforms.

Geographically, North America is poised to lead the veterinary immunodiagnostics market in 2022, followed by Europe and Asia-Pacific, supported by robust veterinary diagnostics infrastructure, heightened awareness of animal health, and substantial investments in pet care.

Key market players include IDEXX Laboratories, Inc. (U.S.), Zoetis Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Virbac (France), Heska Corporation (U.S.), Randox Laboratories, Ltd. (U.S.), Neogen Corporation (U.S.), QIAGEN N.V. (Germany), Abaxis, Inc. (U.S.), and bioMérieux S.A. (France).

For more information and to download a free sample report, visit Meticulous Research®.

To learn more about Meticulous Research® and its services, visit their LinkedIn page or contact them via email at [email protected] or by phone at +1-646-781-8004.